Listen to Avak Kahvejian, Flagship General Partner, describe milestones for Flagship-founded ProFound™ Therapeutics and Ampersand Biomedicines, a vision to advance programmable medicines, goals for JPM 2024, and more.

Tune in and read the full transcript of the conversation here: https://www.flagshippioneering.com/stories/pioneering-profile-avak-kahvejian

Q&A with Avak Kahvejian on the Future of Biotech

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, Moderna , Omega Therapeutics, Sana Biotechnology, Seres Therapeutics, and Tessera Therapeutics.